Xiao-Yuan An, Zhi-Peng Guo, Li-Rong Tang, Yue Gao, Na Wang, Ping Li, Chun-Hong Liu
{"title":"重性抑郁症患者自杀意念的海马-前额叶功能磁共振成像特征。","authors":"Xiao-Yuan An, Zhi-Peng Guo, Li-Rong Tang, Yue Gao, Na Wang, Ping Li, Chun-Hong Liu","doi":"10.1016/j.jad.2025.120019","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Although suicidal ideation (SI) represents a critical manifestation associated with major depressive disorder (MDD), existing diagnostic methods remain largely subjective. This study adopted resting-state functional magnetic resonance imaging techniques to examine objective neural biomarkers connected to SI in patients with MDD.</p><p><strong>Methods: </strong>Participants comprised 50 patients with MDD and SI (MDD-SI), 56 patients with MDD without SI, and 55 healthy control individuals (HCs), matched by demographic variables. Regional homogeneity (ReHo) and fractional amplitude of low-frequency fluctuations (fALFF) analyses were conducted to characterize brain activity patterns. The detected neural features underwent independent clinical correlation and support vector machine (SVM) analyses to evaluate their clinical and diagnostic relevance.</p><p><strong>Results: </strong>In MDD-SI subjects, elevated fALFF was observed in the middle frontal and right postcentral gyri, with a marginal increase in the left hippocampus. They exhibited unique hyperactivation in the right orbitofrontal cortex (OFC) as measured by ReHo, distinguishing them from patients with HCs and MDD without SI. Among individuals in the SI group, left hippocampal fALFF exhibited a significant negative association with depression severity scores (p < 0.05). The SVM classifier reached 63.81 % accuracy in distinguishing MDD-SI individuals from HCs based on ReHo in the right lateral OFC.</p><p><strong>Conclusion: </strong>The study provides novel evidence for distinct neural substrates underlying SI in MDD, highlighting the involvement of hippocampal-prefrontal circuits and sensory integration regions. Despite limitations related to cross-sectional design and medication effects, the findings enhance the understanding of suicide-related brain changes and may aid in identifying biological markers of suicide risk.</p>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":" ","pages":"120019"},"PeriodicalIF":4.9000,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hippocampal-prefrontal functional magnetic resonance imaging signature of suicidal ideation in major depressive disorder.\",\"authors\":\"Xiao-Yuan An, Zhi-Peng Guo, Li-Rong Tang, Yue Gao, Na Wang, Ping Li, Chun-Hong Liu\",\"doi\":\"10.1016/j.jad.2025.120019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Although suicidal ideation (SI) represents a critical manifestation associated with major depressive disorder (MDD), existing diagnostic methods remain largely subjective. This study adopted resting-state functional magnetic resonance imaging techniques to examine objective neural biomarkers connected to SI in patients with MDD.</p><p><strong>Methods: </strong>Participants comprised 50 patients with MDD and SI (MDD-SI), 56 patients with MDD without SI, and 55 healthy control individuals (HCs), matched by demographic variables. Regional homogeneity (ReHo) and fractional amplitude of low-frequency fluctuations (fALFF) analyses were conducted to characterize brain activity patterns. The detected neural features underwent independent clinical correlation and support vector machine (SVM) analyses to evaluate their clinical and diagnostic relevance.</p><p><strong>Results: </strong>In MDD-SI subjects, elevated fALFF was observed in the middle frontal and right postcentral gyri, with a marginal increase in the left hippocampus. They exhibited unique hyperactivation in the right orbitofrontal cortex (OFC) as measured by ReHo, distinguishing them from patients with HCs and MDD without SI. Among individuals in the SI group, left hippocampal fALFF exhibited a significant negative association with depression severity scores (p < 0.05). The SVM classifier reached 63.81 % accuracy in distinguishing MDD-SI individuals from HCs based on ReHo in the right lateral OFC.</p><p><strong>Conclusion: </strong>The study provides novel evidence for distinct neural substrates underlying SI in MDD, highlighting the involvement of hippocampal-prefrontal circuits and sensory integration regions. Despite limitations related to cross-sectional design and medication effects, the findings enhance the understanding of suicide-related brain changes and may aid in identifying biological markers of suicide risk.</p>\",\"PeriodicalId\":14963,\"journal\":{\"name\":\"Journal of affective disorders\",\"volume\":\" \",\"pages\":\"120019\"},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2025-12-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of affective disorders\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jad.2025.120019\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/8 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of affective disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jad.2025.120019","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/8 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Hippocampal-prefrontal functional magnetic resonance imaging signature of suicidal ideation in major depressive disorder.
Background: Although suicidal ideation (SI) represents a critical manifestation associated with major depressive disorder (MDD), existing diagnostic methods remain largely subjective. This study adopted resting-state functional magnetic resonance imaging techniques to examine objective neural biomarkers connected to SI in patients with MDD.
Methods: Participants comprised 50 patients with MDD and SI (MDD-SI), 56 patients with MDD without SI, and 55 healthy control individuals (HCs), matched by demographic variables. Regional homogeneity (ReHo) and fractional amplitude of low-frequency fluctuations (fALFF) analyses were conducted to characterize brain activity patterns. The detected neural features underwent independent clinical correlation and support vector machine (SVM) analyses to evaluate their clinical and diagnostic relevance.
Results: In MDD-SI subjects, elevated fALFF was observed in the middle frontal and right postcentral gyri, with a marginal increase in the left hippocampus. They exhibited unique hyperactivation in the right orbitofrontal cortex (OFC) as measured by ReHo, distinguishing them from patients with HCs and MDD without SI. Among individuals in the SI group, left hippocampal fALFF exhibited a significant negative association with depression severity scores (p < 0.05). The SVM classifier reached 63.81 % accuracy in distinguishing MDD-SI individuals from HCs based on ReHo in the right lateral OFC.
Conclusion: The study provides novel evidence for distinct neural substrates underlying SI in MDD, highlighting the involvement of hippocampal-prefrontal circuits and sensory integration regions. Despite limitations related to cross-sectional design and medication effects, the findings enhance the understanding of suicide-related brain changes and may aid in identifying biological markers of suicide risk.
期刊介绍:
The Journal of Affective Disorders publishes papers concerned with affective disorders in the widest sense: depression, mania, mood spectrum, emotions and personality, anxiety and stress. It is interdisciplinary and aims to bring together different approaches for a diverse readership. Top quality papers will be accepted dealing with any aspect of affective disorders, including neuroimaging, cognitive neurosciences, genetics, molecular biology, experimental and clinical neurosciences, pharmacology, neuroimmunoendocrinology, intervention and treatment trials.